Susquehanna International Group, LLP Ptc Therapeutics, Inc. Put Options Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$30.39 - $37.66 $2.01 Million - $2.49 Million	-66,000 Reduced 89.8%	7,500 $278,000
Q2 2024 Aug 15, 2024	BUY	$24.69 - $40.12 $945,627 - $1.54 Million	38,300 Added 108.81%	73,500 $2.25 Million
Q1 2024 May 07, 2024	BUY	$24.15 - $31.95 $483,000 - $639,000	20,000 Added 131.58%	35,200 $1.02 Million
Q4 2023 Feb 14, 2024	BUY	$18.07 - $29.37 $18,070 - $29,370	1,000 Added 7.04%	15,200 $418,000
Q3 2023 Nov 14, 2023	SELL	$22.41 - $41.99 $197,208 - $369,512	-8,800 Reduced 38.26%	14,200 $318,000
Q2 2023 Aug 11, 2023	BUY	$40.4 - $59.1 $589,840 - $862,860	14,600 Added 173.81%	23,000 $935,000
Q1 2023 May 16, 2023	SELL	$38.16 - $48.86 $1.76 Million - $2.26 Million	-46,200 Reduced 84.62%	8,400 $406,000
Q4 2022 Feb 14, 2023	BUY	$33.53 - $54.79 $486,185 - $794,455	14,500 Added 36.16%	54,600 $2.08 Million
Q3 2022 Nov 14, 2022	BUY	$41.85 - $53.85 $1.18 Million - $1.52 Million	28,300 Added 239.83%	40,100 $2.01 Million

219

78.2M

111K

30.6K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.03B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.